This topic contains a solution. Click here to go to the answer

Author Question: When will a patient who has received ibritumomab tiuxetan with yttrium-90 (IT-Y90) reach the ... (Read 57 times)

sheilaspns

  • Hero Member
  • *****
  • Posts: 567
When will a patient who has received ibritumomab tiuxetan with yttrium-90 (IT-Y90) reach the hematologic nadir?
 
  1. During days 5-10
  2. 10-14 days after infusion
  3. In 30 days
  4. In 7-9 weeks

Question 2

To help minimize side effects in a cancer patient receiving interferon-alfa therapy, the nurse should:
 
  1. start oxygen.
  2. lower the ambient temperature.
  3. provide antiemetics.
  4. administer acetaminophen.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

meow1234

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

Correct Answer: 4

Answer to Question 2

Correct Answer: 4




sheilaspns

  • Member
  • Posts: 567
Reply 2 on: Jul 23, 2018
:D TYSM


Animal_Goddess

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Gracias!

 

Did you know?

After a vasectomy, it takes about 12 ejaculations to clear out sperm that were already beyond the blocked area.

Did you know?

Increased intake of vitamin D has been shown to reduce fractures up to 25% in older people.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

Alcohol acts as a diuretic. Eight ounces of water is needed to metabolize just 1 ounce of alcohol.

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

For a complete list of videos, visit our video library